<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>63 evaluable patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 15 with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) were randomized between low-dose ara-C (arm A) and low dose ara-C in combination with <z:chebi fb="0" ids="6067">13-cis-retinoic acid</z:chebi> (13-CRA) and 1 alpha-hydroxy-<z:chebi fb="0" ids="28940">vitamin D3</z:chebi> (1 alpha D3) (arm B) </plain></SENT>
<SENT sid="1" pm="."><plain>69 patients were evaluable and 18 (26.1%) responded to therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The addition of 13-CRA and 1 alpha D3 had no positive influence on survival of the patients, remission rates or duration of remissions </plain></SENT>
<SENT sid="3" pm="."><plain>12/27 patients in arm A and 6/29 patients in arm B progressed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> during the course of the study (p = 0.0527) </plain></SENT>
<SENT sid="4" pm="."><plain>Arm B gave significantly more side-effects than arm A (p = 0.005) </plain></SENT>
<SENT sid="5" pm="."><plain>Therapeutic effects of 13-CRA and 1 alpha D3 on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is not supported by this study </plain></SENT>
<SENT sid="6" pm="."><plain>However, an inhibiting effect on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> development in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subgroups cannot be excluded </plain></SENT>
</text></document>